BioSpace News Archive

When new safety concerns arise for particular devices, we’re committed to taking action to develop post-market information that can help patients and providers make more informed decisions and also support regulatory actions that reduce any potential risks to patients.

Health care generates vast amounts of data that have the potential to drive medical research and improve health, but unlocking the power of those data for the greater good is often slow and challenging. To address this, Regenstrief Institute of Indianapolis and MDClone of Israel have formed a partnership that aims to speed access to data for medical research, while ensuring patient privacy.

Recently, Admera Health (www.admerahealth.com), unveiled an expansion to its next generation sequencing (NGS) based LiquidGx™ test for solid tumor-targeted therapy selection from a blood sample.

Newest patents significantly strengthen S1 intellectual property position

Starling Brands, Inc. is pleased to announce that in March 2018, they opened their 100% wholly owned subsidiary, Kase Manufacturing Inc.,(“Kase”) an extraction, manufacturing, cultivation and distribution center in Ceres, California.

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco

CONMED Corporation today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Wednesday, January 9, 2019 in San Francisco, CA.

SpringWorks Therapeutics, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7, 2019, at 10:30 a.m. Pacific Standard Time.

Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today provided a clinical enrollment update.

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetics companies, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 8:30 a.m. Pacific at the Westin St. Francis Hotel in San Francisco.